期刊文献+

荧光原位杂交技术在膀胱癌诊断中的临床应用研究 被引量:6

The clinical application of fluoresence in situ hybridization in diagnosis of bladder neoplasms
暂未订购
导出
摘要 目的探讨利用荧光原位杂交(fluorescence in situ hybridization,FISH)技术提高早期诊断膀胱癌的可能性。方法收集20例健康成人的晨尿用FISH技术检测3号、7号、9号p16位点和17号染色体的变异情况,统计出相应阈值。收集100例膀胱癌疑似患者的晨尿,分别进行尿脱落细胞学检查和FISH技术检测。统计学方法分析FISH技术的敏感性、特异性及与膀胱癌发生、发展的关系。结果100例膀胱癌疑似患者的尿液FISH检测的敏感度为87.50%,特异度为80.00%,总阳性率为79.00%;尿脱落细胞学检查的敏感度为61.54%,特异度为83.33%,总阳性率为49.00%。两种检测方法在敏感度和总阳性率上的差异均具有统计学意义,特异度上差异无统计学意义。FISH检测与膀胱癌的病理分级和临床分期均无相关性。结论FISH技术能成为一种提高中国人群膀胱癌早期诊断及监测膀胱癌预后的新方法。 Objective To improve early diagnosis of carcinoma of bladder with in situ hybrid- ization technology. Methods Twenty specimen were collected from healthy people. The abnormality of the third, 7th, 17th, and P16 dot at 9th chromosome were detected with FISH technology. The corresponding threshold is calculated. Fresh urine samples from 100 patients suspect of carcinoma of bladder were collected and detected with exfoliocytology and FISH technology. The sensitivity, specificity and relations with development of carcinoma of bladder is analyzed. Results The sensitivity and specificity of FISH were 87.50% and 80.00%, respectively, with the total positive rate being 79.00% . The sensitivity and specificity of urine exfoliocytology were 61.54% and 83. 33%, respectively, with total positive rate being 49.00%. Significant difference had been noted in the sensitivity and the total positive rate hut specificity between the FISH and exfoliocytology detection. The FISH examination and the elevation of graduation of carcinoma of bladder have no significant difference. Conclusions FISH technology will he a new and excellent detecting technology to increase the early diagnosis rate and prodict the prognosise of carcinoma of bladder.
出处 《现代泌尿生殖肿瘤杂志》 2010年第1期34-37,共4页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 膀胱肿瘤 原位杂交 荧光 Urinary bladder neoplasms In situ hybridization, fluorescence
  • 相关文献

参考文献1

二级参考文献6

  • 1Badalament R A,Hermansen D K,Kimmel M,et al.The sensitivity of bladder wash flow cytometry,bladder wash cytology,and voided cytology in the detection of bladed carcinoma.Cancer,1987,60:1423-1427.
  • 2Stampfer D S,Carpinito G A,Rodriguez-vilianueva J,et al.Evaluation of NMP22 in the detection of transitional cell carcinorma of the bladder.J Urol,1998,159:394-398.
  • 3Murphy W M,Soloway M S,Jukkola A F,et al.Urinary cytology and bladder cancer.The cellular features of transitional cell neoplasms.Cancer,1984,531-555.
  • 4Pardoll D M,Vogelstein B,Coffey D S.A fixed site of DNA replication in eucaryotic cells.Cell,1980,19:527-529.
  • 5Soloway M S,Briggman V,Carpinito G A,et al.Use of a new tumor maker,urinary NMP 22,in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.J Urol,1996,156:363-365.
  • 6Sharma S,Zippe C D,Pandrangi L,et al.Exclusion criteria enhance the specificity and positive predictive value of BNMP 22 and BTA stat.J Urol,1999,162:53-57.

同被引文献83

  • 1穆大为,周利群,丁义,何志嵩,王莹,何群,杨新宇.应用荧光原位杂交技术检测膀胱尿路上皮癌的研究[J].中华临床医师杂志(电子版),2010,4(7):976-980. 被引量:5
  • 2张勤,阮秋蓉,付文荣,周丽梅,盛均逸.原发性胃肠道恶性淋巴瘤临床与病理分析[J].华中科技大学学报(医学版),2005,34(6):764-766. 被引量:2
  • 3李承文,薄丽津,代芸,刘旭平,秦爽,刘世和,王建祥.双色荧光原位杂交技术在检测t(8;21)白血病中的应用[J].中华血液学杂志,2006,27(1):32-35. 被引量:4
  • 4Marin-.Aguilera M, Mengual L, Ribal MJ, et al. Utility ofa multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer [ J ]. Cancer Genet Cytogenet, 2007, 173 (2) :131.
  • 5Constantinou M, Binka-Kowalska A, Borkowske E, et al.Application of multiplex FISH, CGH and MSSCP tech- niques for cytogenetic and molecular analysis of transitional cell carcinoma(TCC) cells in voided urine specimens [ J ]. J Appl Genet ,2006,47 ( 3 ) :273.
  • 6Veeramachaneni R, Nordberg ML, Shi R, et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma [ J 1. Di- agn Cytopathol, 2003,28 ( 6 ) : 301.
  • 7Krfiger S,Mess F, Bhle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predic- tors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder[ J]. Int J 0ncol,2003,23 (1):41.
  • 8Mhawech-Fauceglia P, Fischer G, Beck A, et al. Rafl,Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a ret- rospective TMA study of 246 patients with long-term follow- up [J]. Eur J Surg Oncol,2006,32(4):439.
  • 9Sauter G, Haley J, Chew K, et al. Epidermal-growth-factor receptor expression is associated with rapid tumor prolifera- tion in bladder cancer [J]. Int J Cancer, 1994,57(4): 508.
  • 10Gallucci M, Guadagni F, Marzano R, etal. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7,9, and 17 in advanced Madder cancer: correlation with adjacent mucosa and pathological parameters [ J ]. J Clin Pathol, 2005,58 ( 4 ) : 367.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部